Nothing found

Latest Articles

• 

  Wellgistics Health (NASDAQ:WGRX) and TheracosBio Partner to Expand Nationwide, PBM-Free Access to Brenzavvy(R), an FDA-Approved Diabetes Therapy, Through 6,500+ Pharmacies

  September 30, 2025 Comments Off on Wellgistics Health (NASDAQ:WGRX) and TheracosBio Partner to Expand Nationwide, PBM-Free Access to Brenzavvy(R), an FDA-Approved Diabetes Therapy, Through 6,500+ Pharmacies

  TAMPA, FL  / September 30, 2025 / Wellgistics Health, Inc. (“Wellgistics Health” or the “Company”) (NASDAQ:WGRX), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced a strategic collaboration with TheracosBio, [...]

• 

  Worksport (NASDAQ: WKSP) B2B Sales Surge as Active Dealer Network Expands 42% in One Quarter

  September 30, 2025 Comments Off on Worksport (NASDAQ: WKSP) B2B Sales Surge as Active Dealer Network Expands 42% in One Quarter

• 

  Advent Technologies (NASDAQ: ADN) to Supply MEA’s to Siqens GmbH for its Fuel Cell Systems

  September 29, 2025 Comments Off on Advent Technologies (NASDAQ: ADN) to Supply MEA’s to Siqens GmbH for its Fuel Cell Systems

• 

  Hoth Therapeutics Expands HT-001 Development with Patent Filings Targeting Drug-Induced Hypersensitivity, Radiotherapy-Induced Rash, and MENIN Inhibitor-Associated Skin Toxicities

  September 25, 2025 Comments Off on Hoth Therapeutics Expands HT-001 Development with Patent Filings Targeting Drug-Induced Hypersensitivity, Radiotherapy-Induced Rash, and MENIN Inhibitor-Associated Skin Toxicities

• 

  Worksport (NASDAQ: WKSP) Corporate Update: Record Margins, Strategic Expansion, Imminent Product Launch

  September 25, 2025 Comments Off on Worksport (NASDAQ: WKSP) Corporate Update: Record Margins, Strategic Expansion, Imminent Product Launch